VERSO HEALTHCARE acquires MDL to increase its international development.
MDL, a Swiss financing company created in 1997, has become the leader in medical equipment financing on the Swiss market. Independence from banks and medical equipment manufacturers, personalized support for clients and partners, flexibility and reactivity are the common points that bring the two companies together today.
We asked Erick Roux and Maurice Lehmann, founders of MDL, the reasons for this rapprochement with VERSO HEALTHCARE.
Why join the VERSO HEALTHCARE group in 2020?
MDL was created 22 years ago to support the spectacular evolution of medical technologies through financing. Thus, after having lived through the revolution in diagnostic imaging, surgical robotics and radio-oncology techniques, after having conquered a significant share of the Swiss market of public hospitals, clinics and radiology practices, we have decided to hand over to VERSO HEALTHCARE!
VERSO HEALTHCARE has the same “DNA” as MDL, a European offer and an institutional shareholding, these assets added to a solid team and a long period of support will allow us to continue the development, ensure the continuity of the offer and the durability of MDL.
Christophe SICOT, President and Founder of VERSO HEALTHCARE.
I am extremely happy with the takeover of the MDL company, a pure medical player. This project that we have been working on for a year is now completed. It is in line with our international development objectives
MDL has been a leader on the Swiss market for more than 20 years, with major players in the health sector as customers and partners, as well as extremely solid relationships with financial partners. The work done by MDL is remarkable and is an undeniable asset for the development of the Verso Healthcare project.
Their know-how and their ambitions in supporting clients and partners are very similar to ours. We will be keen to learn about their practices and benefit from their experience in high-level financing, and to bring to the company the full range of offerings from the Verso sphere. MDL with an asset base of more than 130 million euros allows us to continue to grow strongly in this market.
This strategic positioning also constitutes for the medical manufacturers, partners of MDL and VERSO HEALTHCARE, an additional opportunity to increase the penetration of their offers in Switzerland, France, Benelux and Italy.
I would like to thank the MDL team and especially Erick and Maurice for the exchanges that have allowed the construction of this future project.
